SCHEMBL5566917

SCHEMBL5566917

COc1cc2c(Oc3cc(-c4ccccc4)[nH]n3)ncnc2cc1OCCn1ccnc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.49
▸ KDR P35968 6/20 0.48
▸ FLT1 P17948 2/20 0.48
▸ FGFR1 P11362 1/20 0.48
▸ PDGFRB P09619 4/20 0.43
▸ IRAK1 P51617 1/20 0.42
▸ IRAK4 Q9NWZ3 1/20 0.42
▸ CHEK1 O14757 2/20 0.41
▸ FLT4 P35916 4/20 0.40
▸ AURKA O14965 4/20 0.40
▸ TEK Q02763 3/20 0.40
▸ AURKB Q96GD4 3/20 0.40
▸ KDM1A O60341 2/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ TUBB1 Q9H4B7 1/20 0.40
▸ CYP19A1 P11511 2/20 0.39
▸ MET P08581 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5566014 0.99 EGFR (0.48) EGFRKDRFLT1FGFR1PDGFRB
SCHEMBL5565868 0.84 KDM1A (0.56) EGFRKDRFLT1FGFR1PDGFRB
SCHEMBL5566781 0.84 EGFR (0.50) EGFRKDRPDGFRBIRAK1IRAK4
Hydrochloric Acid SCHEMBL5566986 0.83 KDM1A (0.55) EGFRKDRFLT1FGFR1PDGFRB
SCHEMBL5566656 0.82 KDM1A (0.53) EGFRKDRFLT1FGFR1PDGFRB
SCHEMBL5565932 0.82 KDR (0.60) EGFRKDRFLT1FGFR1PDGFRB
Hydrochloric Acid SCHEMBL5566338 0.81 KDM1A (0.52) EGFRKDRFLT1FGFR1PDGFRB
SCHEMBL7885709 0.81 KDR (0.53) EGFRKDRFLT1FGFR1PDGFRB
SCHEMBL7884841 0.80 KDM1A (0.41) EGFRKDRPDGFRBIRAK1IRAK4
SCHEMBL5565918 0.80 SRC (0.57) EGFRKDRPDGFRBCHEK1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 — — US claimed
EP-1119567-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-05-04 — — EP claimed
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 — — US disclosed
EP-1119567-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-05-04 — — EP disclosed
Send feedback